This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiGiandomenico, A.
Right arrow Articles by Goldberg, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiGiandomenico, A.
Right arrow Articles by Goldberg, J. B.

 Previous Article  |  Next Article 

Infection and Immunity, December 2004, p. 7012-7021, Vol. 72, No. 12
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.12.7012-7021.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Oral Vaccination of BALB/c Mice with Salmonella enterica Serovar Typhimurium Expressing Pseudomonas aeruginosa O Antigen Promotes Increased Survival in an Acute Fatal Pneumonia Model

Antonio DiGiandomenico, Jayasimha Rao, and Joanna B. Goldberg*

Department of Microbiology, University of Virginia Health Sciences Center, Charlottesville, Virginia

Received 7 May 2004/ Returned for modification 29 July 2004/ Accepted 16 August 2004

Pseudomonas aeruginosa is a leading cause of nosocomial pneumonia. We compared the efficacies of oral and intraperitoneal (i.p.) vaccinations of BALB/c mice with attenuated Salmonella enterica serovar Typhimurium SL3261 expressing P. aeruginosa serogroup O11 O antigen to protect against P. aeruginosa infection in an acute fatal pneumonia model. Oral and i.p. vaccines elicited O11-specific serum immunoglobulin G (IgG) antibodies, but IgA was observed only after oral immunization. Challenge of orally vaccinated mice with an O11 strain (9882-80) at 6 and 12 times the 50% lethal dose showed increased survival in mice that received the vaccine compared to phosphate-buffered saline (PBS)- and vector-treated controls; no difference in survival was seen with a heterologous strain, 6294 (serogroup O6). In addition, significant protection against 9882-80 was not observed in i.p. vaccinated animals. Bronchoalveolar lavage fluid taken from immunized mice harbored O11-specific IgA and IgG in orally immunized mice but only modest levels of IgG in i.p. vaccinated mice. To correlate protection, opsonophagocytosis assays were performed with pooled sera from orally immunized animals. Efficient killing of five O11 clinical isolates was observed, while no killing was noted with 6294, indicating that the recombinant SL3261 oral vaccine induces an O11-specific reaction. We next determined the ability of orally vaccinated animals to clear bacteria from their lungs. Following P. aeruginosa challenge, the numbers of viable bacteria were significantly fewer in orally vaccinated animals than in PBS- and vector-treated controls. Our results suggest that oral immunization with recombinant SL3261 is efficacious in protection against pneumonia caused by P. aeruginosa.

* Corresponding author. Mailing address: Department of Microbiology, University of Virginia Health Sciences Center, Box 800734, 1300 Jefferson Park Ave., Charlottesville, VA 22908. Phone: (434) 243-2774. Fax: (434) 982-1071. E-mail: jbg2b{at}virginia.edu.

Editor: A. D. O'Brien

Infection and Immunity, December 2004, p. 7012-7021, Vol. 72, No. 12
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.12.7012-7021.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Horzempa, J., Held, T. K., Cross, A. S., Furst, D., Qutyan, M., Neely, A. N., Castric, P. (2008). Immunization with a Pseudomonas aeruginosa 1244 Pilin Provides O-Antigen-Specific Protection. CVI 15: 590-597 [Abstract] [Full Text]  
  • Cross, A. S., Chen, W. H., Levine, M. M. (2008). A case for immunization against nosocomial infections. J. Leukoc. Biol. 83: 483-488 [Abstract] [Full Text]  
  • Scarff, J. M., Goldberg, J. B. (2008). Vaccination against Pseudomonas aeruginosa Pneumonia in Immunocompromised Mice. CVI 15: 367-375 [Abstract] [Full Text]  
  • DiGiandomenico, A., Rao, J., Harcher, K., Zaidi, T. S., Gardner, J., Neely, A. N., Pier, G. B., Goldberg, J. B. (2007). Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections. Proc. Natl. Acad. Sci. USA 104: 4624-4629 [Abstract] [Full Text]  
  • Mueller-Ortiz, S. L., Hollmann, T. J., Haviland, D. L., Wetsel, R. A. (2006). Ablation of the complement C3a anaphylatoxin receptor causes enhanced killing of Pseudomonas aeruginosa in a mouse model of pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L157-L165 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»